IL7 and neoplasm: Taking advantage of the inherent tumor-homing ability of MSCs, MSCs engineered to produce both IL-7 and IL-12, which are critical in the survival and protective responses of T cells, converted from the inhibitory to the stimulatory TME and enhanced the maintenance and anti-tumor activity of CAR-T cells [158].